Postoperative therapy modalities for cervical carcinoma.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Anticancer Research

• Publication date

  2006-03-01

• Fields of study

  Medicine

• Identifiers
  PMID 16617565
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Concurrent cisplatin/gemcitabine chemotherapy along with radiotherapy in locally advanced cervical carcinoma: a phase II trial.

  2006cited by this paper
• Quality of life (QOL) outcomes from a randomized trial of cisplatin versus cisplatin plus paclitaxel in advanced cervical cancer: a Gynecologic Oncology Group study.

  2006cited by this paper
• Weekly gemcitabine and cisplatin in combination with pelvic radiation in the primary therapy of cervical cancer: a phase I trial of the Puget Sound Oncology Consortium.

  2006cited by this paper
• Quality of life outcomes from a randomized phase III trial of cisplatin with or without topotecan in advanced carcinoma of the cervix: a Gynecologic Oncology Group Study.

  2005cited by this paper
• Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: a Gynecologic Oncology Group Study.

  2005cited by this paper
• Randomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervix cancer: a gynecologic oncology group study.

  2005cited by this paper
• Concurrent chemotherapy and radiotherapy in locally advanced cervical carcinoma (LACC): Anályis of two different radiosensitizer schedules

  2005cited by this paper
• Rethinking the use of radiation and chemotherapy after radical hysterectomy: a clinical-pathologic analysis of a Gynecologic Oncology Group/Southwest Oncology Group/Radiation Therapy Oncology Group trial.

  2005cited by this paper
• Concurrent chemotherapy and radiotherapy for the treatment of cervix uterine cancer at experience in a general hospital

  2005cited by this paper
• Cancer-Related Anemia: Biological Findings, Clinical Implications and Impact on Quality of Life

  2005cited by this paper
• Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix.

  2005cited by this paper
• [Prognostic value of anemia for patients with cervical cancer treated with irradiation].

  2005cited by this paper
• First line treatment of cervical adenocarcinoma with paclitaxel and carboplatin

  2005cited by this paper
• Weekly paclitaxel and carboplatin (WTJ) neo-adjuvant chemotherapy (NAC) for high-risk cervical cancer is well tolerated by Japanese women

  2005cited by this paper
• Phase I/II study of gemcitabine (GEM) and concomitant radiotherapy (RT) in locally advanced carcinoma of the cervix (LACC)

  2005cited by this paper
• Pathologic response and toxicity assessment of chemoradiotherapy with cisplatin versus cisplatin plus gemcitabine in cervical cancer: a randomized Phase II study.

  2005cited by this paper
• Concurrent weekly cisplatin and radiotherapy in routine management of cervical cancer: a report on patient compliance and acute toxicity.

  2004cited by this paper
• Hypoxia and anemia: factors in decreased sensitivity to radiation therapy and chemotherapy?

  2004cited by this paper
• Phase II study of cisplatin and vinorelbine in squamous cell carcinoma of the cervix: a gynecologic oncology group study.

  2004cited by this paper
• Cisplatin and irinotecan in squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group.

  2004cited by this paper
• Adjuvant radiotherapy in carcinomas of the uterine cervix: the prognostic value of hemoglobin levels

  2004cited by this paper
• Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group study.

  2004cited by this paper
• Cisplatin and gemcitabine in patients with metastatic cervical cancer.

  2004cited by this paper
• Effect of hemoglobin solution on the response of intracranial and subcutaneous 9L tumors to antitumor alkylating agents

  2004cited by this paper
• A systematic review of acute and late toxicity of concomitant chemoradiation for cervical cancer.

  2003cited by this paper
• Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis

  2003cited by this paper
• Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial.

  2003cited by this paper
• CONCOMITANT CHEMO-RADIO BRACHYTHERAPY WITH CISPLATIN AND TAXOL IN ADVANCED SQUAMOUS CELL CARCINOMA (ASCC) OF THE CERVIX UTERI

  2003cited by this paper
• A phase I-II study of weekly cisplatin and gemcitabine with concurrent radiotherapy in locally advanced cervical carcinoma.

  2003cited by this paper
• Phase II clinical study of irinotecan and cisplatin as first-line chemotherapy in metastatic or recurrent cervical cancer.

  2003cited by this paper
• Breast cancer trial with erythropoietin terminated unexpectedly.

  2003cited by this paper
• Vinorelbine and Cisplatin for the Treatment of Recurrent and/or Metastatic Carcinoma of the Uterine Cervix

  2002cited by this paper
• Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review.

  2001cited by this paper
• Global cancer statistics in the year 2000.

  2001cited by this paper
• Anemia as an independent prognostic factor for survival in patients with cancer

  2001cited by this paper
• A Phase II study of topotecan in patients with squamous cell carcinoma of the cervix: a gynecologic oncology group study.

  2001cited by this paper
• Phase II study of concurrent gemcitabine and radiotherapy in locally advanced stage IIIB cervical carcinoma.

  2001cited by this paper
• [Adjuvant chemotherapy of cervix carcinoma--results of a phase II study].

  2001cited by this paper
• A phase III, double-blind, placebo-controlled, randomized study of novel erythropoiesis stimulating protein (NESP) in patients undergoing platinum-treatment for lung cancer

  2001cited by this paper
• Die adjuvante Chemotherapie des Zervixkarzinoms - Ergebnisse einer Phase II-Studie

  2001cited by this paper
• Erythropoietin and anemia of cancer

  2000cited by this paper
• Phase II Study of Irinotecan and Cisplatin as First-Line Chemotherapy in Advanced or Recurrent Cervical Cancer

  2000cited by this paper
• Is anemia a problem for European cancer patients and treating oncologists?

  2000cited by this paper
• Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix.

  2000cited by this paper
• Topotecan in squamous cell carcinoma of the cervix: A Phase II study of the Gynecologic Oncology Group.

  2000cited by this paper
• The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix

  1999cited by this paper
• Phase II study of cisplatin and vinorelbine as first-line chemotherapy in patients with carcinoma of the uterine cervix.

  1999cited by this paper
• Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study.

  1999cited by this paper
• Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma.

  1999cited by this paper
• Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.

  1999cited by this paper
• Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.

  1999cited by this paper
• Chemotherapy-induced anemia in adults: incidence and treatment.

  1999cited by this paper
• Enhanced radiosensitivity in experimental tumours following erythropoietin treatment of chemotherapy-induced anaemia.

  1998cited by this paper
• The Functional Assessment of Cancer Therapy-Anemia (FACT-An) Scale: a new tool for the assessment of outcomes in cancer anemia and fatigue.

  1997cited by this paper
• An update of a phase II study of paclitaxel in advanced or recurrent squamous cell cancer of the cervix

  1997cited by this paper
• Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system.

  1997cited by this paper
• Radiosensitization of human solid tumor cell lines with gemcitabine.

  1996cited by this paper
• Erythropoietin and the anemia of cancer.

  1996cited by this paper
• Reduced oxygenation in a rat mammary carcinoma post-radiation and reoxygenation with a perflubron emulsion/carbogen breathing.

  1994cited by this paper
• Sequences of taxol and cisplatin: a phase I and pharmacologic study.

  1991cited by this paper

• Evaluation of the Risk Factors for Pelvic Lymph Node Metastasis in Early Stage Cervical Cancer

  2018cites this paper
• A Pharmacogenetic Predictive Model for Paclitaxel Clearance Based on the DMET Platform

  2013cites this paper
• Thema : p 53 codon 72 polymorphism in HPV-related cervical cancer

  2010cites this paper
• Creation and characterization of a xenograft model for human cervical cancer.

  2010cites this paper
• Radiotherapy and chemoradiation of cervical cancer patients

  2008cites this paper
• Celecoxib Enhances the Chemotherapeutic Response of Cisplatin and TNF-α in SiHa Cells through Reactive Oxygen Species-Mediated Mitochondrial Pathway

  2007influential citation
• Fatores de risco não habituais para metástase linfonodal no câncer do colo do útero

  2007cites this paper
• [Unusual risk factors for lymph node metastasis in cancer of the uterine cervix].

  2007cites this paper
• Prognostic impact of haemoglobin levels in breast cancer.

  2007cites this paper